Evidence map›Paper›PMID 31101919›Full record

ArticleNature chemical biology2019

Structural and mechanistic basis of mammalian Nudt12 RNA deNADding.

Ewa Grudzien-Nogalska, Yixuan Wu, Xinfu Jiao, Huijuan Cui, Maria K Mateyak, Ronald P Hart, Liang Tong, Megerditch Kiledjian

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 69 citations in OpenAlex.

  1. Detection and sequencing of ApProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. RNA modifications and their role in gene expression.Frontiers in molecular biosciences · 2025
    Review
  17. Application of Mammalian Nudix Enzymes to Capped RNA Analysis.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ewa Grudzien-Nogalska *Department Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA.
Yixuan Wu *Department Biological Sciences, Columbia University, New York, NY, USA.
Xinfu JiaoDepartment Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA.
Huijuan CuiDepartment Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA.
Maria K MateyakDepartment Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA.
Ronald P HartDepartment Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA.
Liang TongDepartment Biological Sciences, Columbia University, New York, NY, USA. ltong@columbia.edu.ORCID http://orcid.org/0000-0002-0563-6468
Megerditch KiledjianDepartment Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA. kiledjian@biology.rutgers.edu.ORCID http://orcid.org/0000-0001-8099-0451
Rutgers, The State University of New Jersey · USColumbia University · US

Funding

Overall EvaluationP41GM103403 · NIGMS · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2012 to 2017
$14.3M
Structural and functional studies of mRNA processing, stability and quality controlR35GM118093 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIANG TONG · 2016 to 2026
$8.5M
Eukaryotic RNA NAD+ capping and deNADingR01GM126488 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI KILEDJIAN, MEGERDITCH · 2018 to 2023
$2.4M
Pixel Array Detector for X-ray CrystallographyS10RR029205 · NCRR · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2010 to 2010
$1.8M
Supercomputing: Rutgers' Catalyst for Discovery at the Frontiers of MedicineS10OD012346 · OD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI MICHELSON, LESLIE PAUL · 2015 to 2015
$1.7M
Replacement of an aging X-ray diffraction system for protein crystallographyS10OD012018 · OD · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI TONG, LIANG · 2012 to 2012
$405k
NCRR NIH HHS S10 RR029205NIGMS NIH HHS P41 GM103403NIGMS NIH HHS R01 GM126488NIGMS NIH HHS R35 GM118093NIH HHS S10 OD012018NIH HHS S10 OD012346
6 · The paper itself

Abstract

We recently demonstrated that mammalian cells harbor nicotinamide adenine dinucleotide (NAD)-capped messenger RNAs that are hydrolyzed by the DXO deNADding enzyme. Here, we report that the Nudix protein Nudt12 is a second mammalian deNADding enzyme structurally and mechanistically distinct from DXO and targeting different RNAs. The crystal structure of mouse Nudt12 in complex with the deNADding product AMP and three Mg

Indexed as

HumansNADNudix HydrolasesPyrophosphatasesRNA, MessengerNADNudix HydrolasesNUDT12 protein, humanPyrophosphatasesRNA, Messenger

Identifiers

PMID31101919
PMCPMC6527130
OpenAlexW2946321518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.